These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12792364)

  • 1. Effect of protease inhibitors on apolipoprotein B levels and plasma lipid profile in HIV-1-infected patients on highly active antiretroviral therapy.
    Domingo P; Sambeat MA; Pérez A; Ordoñez J
    J Acquir Immune Defic Syndr; 2003 May; 33(1):114-6. PubMed ID: 12792364
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
    Beatty G; Chu J; Kulkarni K; Lipshutz G; Khalili M; Abbasi F; Stansell J; Reaven GM
    HIV Clin Trials; 2004; 5(6):383-91. PubMed ID: 15682351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.
    Malavazi I; Abrão EP; Mikawa AY; Landgraf VO; da Costa PI
    Clin Chem Lab Med; 2004 May; 42(5):525-32. PubMed ID: 15202789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating hyperlipidaemia associated with antiretroviral therapy.
    Mauss S; Stechel J; Willers R; Schmutz G; Berger F; Richter WO
    AIDS; 2003 Jan; 17(2):189-94. PubMed ID: 12545078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.
    Melvin AJ; Kang M; Hitti J; Livingston E; Cohn SE; Stocker V; Ross AC; Watts H; McComsey GA
    Antivir Ther; 2008; 13(3):349-55. PubMed ID: 18572747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors.
    Montes ML; Pulido F; Barros C; Condes E; Rubio R; Cepeda C; Dronda F; Antela A; Sanz J; Navas E; Miralles P; Berenguer J; Pérez S; Zapata A; González-García JJ; Peña JM; Vázquez JJ; Arribas JR
    J Antimicrob Chemother; 2005 May; 55(5):800-4. PubMed ID: 15761071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood lipid abnormalities during treatment with protease inhibitors].
    Vergès B; Petit JM
    Presse Med; 2001 May; 30(18):911-4. PubMed ID: 11413853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.
    Lainka E; Oezbek S; Falck M; Ndagijimana J; Niehues T
    Pediatrics; 2002 Nov; 110(5):e56. PubMed ID: 12415062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional assessment and lipid profile in HIV-infected children and adolescents treated with highly active antiretroviral therapy.
    Tremeschin MH; Sartorelli DS; Cervi MC; Negrini BV; Salomão RG; Monteiro JP
    Rev Soc Bras Med Trop; 2011; 44(3):274-81. PubMed ID: 21739071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
    Young J; Weber R; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(5):585-91. PubMed ID: 16152752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia in HIV-positive patients receiving antiretrovirals.
    Segarra-Newnham M
    Ann Pharmacother; 2002 Apr; 36(4):592-5. PubMed ID: 11918504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
    J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.
    Li J; Lai H; Chen S; Lai S
    Int J STD AIDS; 2018 Jul; 29(8):781-789. PubMed ID: 29471762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profile during pregnancy in HIV-infected women.
    Floridia M; Tamburrini E; Ravizza M; Tibaldi C; Ravagni Probizer MF; Anzidei G; Sansone M; Mori F; Rubino E; Meli M; Dalzero S; Guaraldi G;
    HIV Clin Trials; 2006; 7(4):184-93. PubMed ID: 17065030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
    Swanson B; Keithley JK; Zeller JM; Sha BE
    Nutrition; 2004; 20(11-12):1022-5. PubMed ID: 15561494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients.
    Negredo E; Ribalta J; Ferré R; Salazar J; Rey-Joly C; Sirera G; Masana L; Clotet B
    AIDS; 2004 Mar; 18(5):819-21. PubMed ID: 15075521
    [No Abstract]   [Full Text] [Related]  

  • 18. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid lowering therapy in patients with HIV infection.
    McBride M; Chin MT; Lee SM; Kelly B
    Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.